Teslexivir | m-entrepreneurship.com

Product Name :
Teslexivir

Search keywords :
Teslexivir

drugId :
null

Target Vo:
Human papillomavirus Replication protein E1

Target Vo Short Name :
E1

Moa_Name:
Virus replication inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Aviragen Therapeutics Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Condylomata Acuminata

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RAGE Antibody web
IKK alpha + IKK beta Rabbit mAb Autophagy
RUNX Antibody: RUNX Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to RUNX. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts